The evolving role of oestrogen receptor beta in clinical breast cancer.

Speirs V.

Breast Cancer Res. 2008;10(5):111. Epub 2008 Sep 19.

PMID: 18831727 [PubMed - in process]

Related Articles

Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients.

Shaaban AM, Green AR, Karthik S, Alizadeh Y, Hughes TA, Harkins L, Ellis IO, Robertson JF, Paish EC, Saunders PT, Groome NP, Speirs V.

Clin Cancer Res. 2008 Aug 15;14(16):5228-35.

PMID: 18698041 [PubMed - indexed for MEDLINE]

Related Articles

Correlation of mRNA for oestrogen receptor beta splice variants ERbeta1, ERbeta2/ERbetacx and ERbeta5 with outcome in endocrine-treated breast cancer.

Davies MP, O'Neill PA, Innes H, Sibson DR, Prime W, Holcombe C, Foster CS.

J Mol Endocrinol. 2004 Dec;33(3):773-82.

PMID: 15591034 [PubMed - indexed for MEDLINE]

Related Articles

Association of oestrogen receptor beta 2 (ER beta 2/ER beta cx) with outcome of adjuvant endocrine treatment for primary breast cancer--a retrospective study.

Vinayagam R, Sibson DR, Holcombe C, Aachi V, Davies MP.

BMC Cancer. 2007 Jul 18;7:131.

PMID: 17640362 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Cloning, characterisation, and expression of three oestrogen receptors (ERalpha, ERbeta1 and ERbeta2) in the European sea bass, Dicentrarchus labrax.

Halm S, Martínez-Rodríguez G, Rodríguez L, Prat F, Mylonas CC, Carrillo M, Zanuy S.

Mol Cell Endocrinol. 2004 Aug 31;223(1-2):63-75.

PMID: 15279912 [PubMed - indexed for MEDLINE]

Related Articles

Plasma c-erbB-2 levels in breast cancer patients: prognostic significance in predicting response to chemotherapy.

Mehta RR, McDermott JH, Hieken TJ, Marler KC, Patel MK, Wild LD, Das Gupta TK.

J Clin Oncol. 1998 Jul;16(7):2409-16.

PMID: 9667258 [PubMed - indexed for MEDLINE]

Related Articles

Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells.

Murphy LC, Peng B, Lewis A, Davie JR, Leygue E, Kemp A, Ung K, Vendetti M, Shiu R.

J Mol Endocrinol. 2005 Apr;34(2):553-66.

PMID: 15821116 [PubMed - indexed for MEDLINE]

Related Articles

Wild-type oestrogen receptor beta (ERbeta1) mRNA and protein expression in Tamoxifen-treated post-menopausal breast cancers.

O'Neill PA, Davies MP, Shaaban AM, Innes H, Torevell A, Sibson DR, Foster CS.

Br J Cancer. 2004 Nov 1;91(9):1694-702.

PMID: 15477865 [PubMed - indexed for MEDLINE]

Related Articles

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID: 17993229 [PubMed - indexed for MEDLINE]

Related Articles

Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours.

Skliris GP, Leygue E, Curtis-Snell L, Watson PH, Murphy LC.

Br J Cancer. 2006 Sep 4;95(5):616-26. Epub 2006 Aug 1.

PMID: 16880783 [PubMed - indexed for MEDLINE]

Related Articles

TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer.

Overgaard J, Yilmaz M, Guldberg P, Hansen LL, Alsner J.

Acta Oncol. 2000;39(3):327-33.

PMID: 10987229 [PubMed - indexed for MEDLINE]

Related Articles

Expression of estrogen receptor beta wt isoform (ERbeta1) and ERbetaDelta5 splice variant mRNAs in sporadic breast cancer.

Mandusić V, Nikolić-Vukosavljević D, Tanić N, Kanjer K, Neskovic-Konstantinović Z, Celeketić D, Dimitrijević B.

J Cancer Res Clin Oncol. 2007 Aug;133(8):571-9. Epub 2007 Apr 25.

PMID: 17457609 [PubMed - indexed for MEDLINE]

Related Articles

The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer.

Nakopoulou L, Lazaris AC, Panayotopoulou EG, Giannopoulou I, Givalos N, Markaki S, Keramopoulos A.

J Clin Pathol. 2004 May;57(5):523-8.

PMID: 15113861 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

p53 as an independent prognostic marker in lymph node-negative breast cancer patients.

Silvestrini R, Benini E, Daidone MG, Veneroni S, Boracchi P, Cappelletti V, Di Fronzo G, Veronesi U.

J Natl Cancer Inst. 1993 Jun 16;85(12):965-70.

PMID: 8496982 [PubMed - indexed for MEDLINE]

Related Articles

Expression of Com-1/P8 in human breast cancer and its relevance to clinical outcome and ER status.

Jiang WG, Watkins G, Douglas-Jones A, Mokbel K, Mansel RE, Fodstad O.

Int J Cancer. 2005 Dec 10;117(5):730-7.

PMID: 15957166 [PubMed - indexed for MEDLINE]

Related Articles

Prognostic significance of oestrogen receptor beta in breast cancer.

Speirs V, Kerin MJ.

Br J Surg. 2000 Apr;87(4):405-9. Review.

PMID: 10759732 [PubMed - indexed for MEDLINE]

Related Articles

Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer.

Chang A, Yousef GM, Scorilas A, Grass L, Sismondi P, Ponzone R, Diamandis EP.

Br J Cancer. 2002 May 6;86(9):1457-64.

PMID: 11986781 [PubMed - indexed for MEDLINE]

Related Articles

Low levels of estrogen receptor beta protein predict resistance to tamoxifen therapy in breast cancer.

Hopp TA, Weiss HL, Parra IS, Cui Y, Osborne CK, Fuqua SA.

Clin Cancer Res. 2004 Nov 15;10(22):7490-9.

PMID: 15569979 [PubMed - indexed for MEDLINE]

Related Articles

The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.

Al Sarakbi W, Mokbel R, Salhab M, Jiang WG, Reed MJ, Mokbel K.

Anticancer Res. 2006 Nov-Dec;26(6C):4985-90.

PMID: 17214375 [PubMed - indexed for MEDLINE]

Related Articles

Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer.

Sainsbury JR, Farndon JR, Needham GK, Malcolm AJ, Harris AL.

Lancet. 1987 Jun 20;1(8547):1398-402.

PMID: 2884496 [PubMed - indexed for MEDLINE]

Related Articles